Targets Conference Showcases Exciting Data from Clinical Trials of Innovative Cancer Therapeutics
There has been an explosion in the number of cancer therapeutics and clinical trials in the recent past, owing...
Tag: NSCLC
There has been an explosion in the number of cancer therapeutics and clinical trials in the recent past, owing...
About 80 percent of lung cancers are non-small cell lung cancers (NSCLC), and about 15 to 20 percent of...
During the early part of November, we saw the U.S. Food and Drug Administration (FDA) approve a new molecularly...
The U.S. Food and Drug Administration (FDA) recently approved expanding the use of the immunotherapeutic durvalumab (Imfinzi) to include...